Potential Side Effects: Gastrointestinal effects (most common): nausea, vomiting, diarrhea, constipation, abdominal paintypically mild to moderate and decreasing with gradual dose escalation [1] [3]
This was in comparison to the control group where both males and females showed increased body adiposity while body adiposity and weight of gonadal fat pads decreased in KIR and KID mice [3]
Scientific References (External Links) The Journal of Immunology: The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses View Study Journal of Experimental Medicine: LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells View Study Journal of Investigative Dermatology: The human antimicrobial peptide LL-37 suppresses apoptosis in keratinocytes View Study Cellular and Molecular Life Sciences: Cathelicidin LL-37: a multitask antimicrobial peptide View Study
But as with any compound, especially one not yet clinically approved for human use , its safety depends on: The quality of the peptide The accuracy of the dose and administration The duration and purpose of your use Your individual health profile and risk tolerance While BPC-157 exhibits an extraordinary safety profile in animals, its long-term safety in humans remains to be fully established. Sikiric, P
